Lung transplantation

Current Opinion in Anaesthesiology

Volumn 20, Issue 1, 2007, Pages 21-26

  Myles, Paul S ^a   Snell, Greg I ^a   Westall, Glen P ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Anesthesia; Gene transfection; Reperfusion injury; Transesophageal echocardiography

Indexed keywords

ANESTHETIC AGENT; APROTININ; CYCLOSPORIN; EVEROLIMUS; INTERLEUKIN 10 ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANGIOCARDIOGRAPHY; CHRONIC GRAFT REJECTION; DEVICE; EXTRACORPOREAL OXYGENATION; GENE REPLACEMENT THERAPY; GENE TARGETING; GENETIC TRANSFECTION; GRAFT RECIPIENT; HEART DEATH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDUCED HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LUNG INJURY; LUNG TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIDE EFFECT; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANESTHESIA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; INTENSIVE CARE; LUNG TRANSPLANTATION; ORGAN PRESERVATION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 33846068151     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328013da0f     Document Type: Review

References (52)

1. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report. J Heart Lung Transplant 2006; 25:880-892. The up-to-date and definitive review of lung transplantation.
2. Myles PS. Pulmonary transplantation. In: Kaplan JA, Slinger P, editors. Thoracic Anesthesia. Harcourt; 2003. pp. 295-314.
3. de Perrot M, Snell GI, Babcock WD, et al. Strategies to optimize the use of currently available lung donors. J Heart Lung Transplant 2004; 23:1127-1134.
4. Gabbay E, Griffiths A, McFarlane L, et al. Maximizing the utilisation of donor organs offered for lung transplantation. Am J Resp Crit Care Med 1999; 160:265-272.
5. Oto T, Griffiths A, Levvey B, et al. A donor history of smoking affects early but not late outcomes post lung transplantation. Transplantation 2004; 78:599-606.
6. Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from nonheart-beating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76:244-252.
7. Date H, Aoe M, Sano Y, et al. Improved survival after living-donor lobar lung transplantation. J Thorac Cardiovasc Surg 2004; 128:933-940.
8. Gamez P, Cordoba M, Ussetti P, et al. Lung transplantation from out-of-hospital nonheart-beating lung donors. One-year experience and results. J Heart Lung Transplant 2005; 24:1098-1102. A report of their initial experience of 5 cases of LTx from donors after cardiac death, with excellent results.
9. Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplantation 2005; 24:1454-1459. An expert summary of current evidence.
10. Cottini SR, Lerch N, de Perrot M, et al. Risk factors for reperfusion injury after lung transplantation. Intensive Care Med 2006; 32:557-563. A retrospective analysis of 60 LTx procedures identifying factors associated with reperfusion injury.
11. Guillen RV, Briones FR, Marin PM, et al. Lung graft dysfunction in the early postoperative period after lung and heart lung transplantation. Transplant Proc 2005; 37:3994-3995.
12. Wittwer T, Albes JM, Fehrenbach A, et al. Experimental lung preservation with Perfadex: effect of the NO-donor nitroglycerin on postischemic outcome. J Thorac Cardiovasc Surg 2003; 125:1208-1216.
13. Oto T, Griffiths AP, Rosenfeldt F, et al. Preservation solutions in lung transplantation: Outcomes from Perfadex, Papworth, and Euro-Collins Solutions. Ann Thorac Surg 2006; 82:1842-1848. A retrospective analysis of outcomes after LTx found that Perfadex resulted in superior gas exchange early after surgery.
14. Christie JD, Van Raemdonck D, de Perrot M, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part 1: introduction and methods. J Heart Lung Transplant 2005; 24:1451-1453. An expert summary of current evidence.
15. Oto T, Rabinov M, Griffiths A, et al. Unexpected donor pulmonary embolism affects early outcomes following lung transplantation: A major mechanism of primary graft failure? J Thorac Cardiovasc Surg 2005; 130:1441-1446.
16. Wittwer T, Franke UF, Fehrenbach A, et al. Experimental lung transplantation: impact of preservation solution and route of delivery. J Heart Lung Transplant 2005; 24:1081-1090. Using a pig model, Perfadex solution provided lung preservation for 27 h of cold ischemia; retrograde application was superior to antegrade perfusion.
17. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167:490-511.
18. Oto T, Levvey B, Pilcher D, et al. Evaluation of the oxygenation ratio in the definition of early graft dysfunction post lung transplantation. J Thorac Cardiovasc Surg 2005; 130:180-186.
19. Bittner HB, Richter M, Kuntze T, et al. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg 2006; 29:210-215. When compared with an historical control group, the introduction of aprotinin in LTx had beneficial effects on patient outcomes and ischemia-reperfusion injury.
20. Carless PA, Moxey AJ, Stokes BJ, Henry DA. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials. BMC Cardiovasc Disord 2005; 5:19. A meta-analysis of randomized trials could not identify superior blood conservation with aprotinin when compared to the lysine analogs.
21. Perrin G, Roch A, Michelet P, et al. Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation measured by lung water content: a randomized clinical study. Chest 2006; 129:1024-1030.
22. Sato M, Keshavjee S. Gene therapy in lung transplantation. Curr Gene Ther 2006; 6:439-458.
23. Kaneda H, Waddell TK, de Perrot M, et al. Preimplantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006; 6:544-551.
24. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update. J Heart Lung Transplant 2006; 25:745-756.
25. Ben-Dor I, Kramer MR, Raccah A, et al. Echocardiography versus right-sided heart catheterization among lung transplantation candidates. Ann Thorac Surg 2006; 81:1056-1060.
26. Choong CK, Meyers BF, Guthrie TJ, et al. Does the presence of preoperative mild or moderate coronary artery disease affect outcomes of lung transplantation? Ann Thorac Surg 2006; 82:1038-1042.
27. Parekh K, Meyers BF, Patterson GA, et al. Outcome of lung transplantation for patients requiring concomitant cardiac surgery. J Thorac Cardiovasc Surg 2005; 130:859-863.
28. Fischer S, Simon AR, Welte T, et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg 2006; 131:719-723.
29. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006; 6:1212-1227.
30. Aigner C, Jaksch P, Taghavi S, et al. Donor total lung capacity predicts recipient total lung capacity after size-reduced lung transplantation. J Heart Lung Transplant 2005; 24:2098-2102.
31. Boucek MM, Waltz DA, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplant report. J Heart Lung Transplant 2006; 25:893-903.
32. Dalibon N, Geffroy A, Moutafis M, et al. Use of cardiopulmonary bypass for lung transplantation: a 10-year experience. J Cardiothorac Vasc Anesth 2006; 20:668-672. A large case series from an experienced unit found CPB was associated with poorer outcome after LTx.
33. Force SD, Miller DL, Pelaez A, et al. Outcomes of delayed chest closure after bilateral lung transplantation. Ann Thorac Surg 2006; 81:2020-2024.
34. Riegle EV, Otto AA, Krucylak CP. Recall of intraoperative events during pediatric lung transplantation. Anesth Analg 1996; 82:S380.
35. Myles PS, Leslie K, Forbes A, et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet 2004; 363:1757-1763.
36. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575.
37. Pilcher DV, Scheinkestel CD, Snell GI, et al. A high central venous pressure is associated with prolonged mechanical ventilation and increased mortality following lung transplantation. J Thoracic Cardiovasc Surg 2005; 129:912-918.
38. Hill GE, Frawley WH, Griffith KF, et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003; 54:908-914.
39. Ferraris VA, Ferraris SP, Moliterno DJ, et al. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization. Ann Thorac Surg 2005; 79:1454-1461.
40. Mangano DT, Tudor IC, Dietzel C, et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354:353-365.
41. Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion- risk cardiac surgery. Transfusion 2006; 46:327-338.
42. Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy: a systematic review and meta-analysis of randomized trials. Br J Anaesth 2006; 96:418-426.
43. Izbicki G, Bairey O, Shitrit D, et al. Increased thromboembolic events after lung transplantation. Chest 2006; 129:412-416.
44. Huang YC, Cheng YJ, Lin YH, et al. Graft failure caused by pulmonary venous obstruction diagnosed by intraoperative transesophageal echocardiography during lung transplantation. Anesth Analg 2000; 91:558-560.
45. Cywinski JB, Wallace L, Parker BM. Pulmonary vein thrombosis after sequential double-lung transplantation. J Cardiothorac Vasc Anesth 2005; 19:225-227. The first report of pulmonary vein thrombosis detected by intraoperative TEE.
46. McIlroy DR, Cairo SA, Buckland MR. Pulmonary vein thrombosis, lung transplantation, and intraoperative transesophageal echocardiography. J Cardiothorac Vasc Anesth 2006; 20:712-715. A series of 3 cases of pulmonary vein/left atrial thrombosis in LTx.
47. Oto T, Rosenfeldt F, Rowland M, et al. Extracorporeal oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg 2004; 78:1230-1235.
48. Mason DP, Boffa DJ, Murthy SC, et al. Extend use of extracorporeal membrane oxygenation after lung transplantation. J Thorac Cardiovasc Surg 2006; 132:954-960.
49. Australian and New Zealand Organ Donation Registry. 2006 report. Woodville South: ANZOD Registry available from http://www.ANZDATA.org.au.
50. Iacono AT, Johnson BA, Grgurich WF, et al. A randomized trial of inhaled cyclosporine in lung transplant recipients. N Engl J Med 2006; 354:141-150. An excellent clinical trial showing that inhaled cyclosporine did not improve acute rejection, but did extend chronic rejection-free survival and improve overall survival.
51. Snell GI, Valentine VG, Vitulo P, et al. Everolimus versus Azathioprine as Adjunctive Therapy to Inhibit the Lung Function Decline in Stable Lung Transplant Recipients: 12 and 24-Month Results of an International, Randomized Double-Blind Study. Am J Transplant 2006; 6:169-177.
52. McNeil K, Glanville AR, Wahlers T, et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation 2006; 81:998-1003.